Recombinant Pseudorabies Virus Usage in Vaccine Development against Swine Infectious Disease
Viruses · 28.01.2023 · 15 (2) · 370
DOI: 10.3390/v15020370 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 28.01.2023. Verfasst von Mo Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for High-Tech Research and Development of Veterinary Biopharmaceuticals, Engineering Technology Research Center for Modern Ani…. Hauptthemen laut MEDLINE: Pseudorabies, Herpesvirus 1, Suid, Communicable Diseases, Alphaherpesvirinae. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: key project of Jiangsu Province’s Key Research and Development Plan (modern Agriculture), project of Jiangsu Agri-animal Husbandry Vocational College, Natural Science Research Project of Higher Education of Jiangsu Province.
Abstract (Originalsprache)
Pseudorabies virus (PRV) is the pathogen of pseudorabies (PR), which belongs to the alpha herpesvirus subfamily with a double stranded DNA genome encoding approximately 70 proteins. PRV has many non-essential regions for replication, has a strong capacity to accommodate foreign genes, and more areas for genetic modification. PRV is an ideal vaccine vector, and multivalent live virus-vectored vaccines can be developed using the gene-deleted PRV. The immune system continues to be stimulated by the gene-deleted PRVs and maintain a long immunity lasting more than 4 months. Here, we provide a brief overview of the biology of PRV, recombinant PRV construction methodology, the technology platform for efficiently constructing recombinant PRV, and the applications of recombinant PRV in vaccine development. This review summarizes the latest information on PRV usage in vaccine development against swine infectious diseases, and it offers novel perspectives for advancing preventive medicine through vaccinology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory for High-Tech Research and Development of Veterinary Biopharmaceuticals, Engineering Technology Research Center for Modern Animal Science and Novel Veterinary Pharmaceutic Development, Jiangsu Agr…
- Viral Oncogenesis Group, The Pirbright Institute, Ash Road Pirbright, Woking, Surrey GU24 0NF, UK.
ORCID-Profile: Mo Zhou, Muhammad Abid
Förderung
- key project of Jiangsu Province’s Key Research and Development Plan (modern Agriculture)
- project of Jiangsu Agri-animal Husbandry Vocational College
- Natural Science Research Project of Higher Education of Jiangsu Province
- Qing Lan Project of Jiangsu Province
Zitieren
APA
Zhou, M., Abid, M., Cao, S., & Zhu, S. (2023). Recombinant Pseudorabies Virus Usage in Vaccine Development against Swine Infectious Disease. Viruses, 15(2), 370. https://doi.org/10.3390/v15020370
Vancouver
Zhou M, Abid M, Cao S, Zhu S. Recombinant Pseudorabies Virus Usage in Vaccine Development against Swine Infectious Disease. Viruses. 2023;15(2):370. doi:10.3390/v15020370
BibTeX
@article{Zhou2023,
author = {Zhou, Mo and Abid, Muhammad and Cao, Shinuo and Zhu, Shanyuan},
title = {Recombinant Pseudorabies Virus Usage in Vaccine Development against Swine Infectious Disease},
journal = {Viruses},
year = {2023},
volume = {15},
number = {2},
pages = {370},
doi = {10.3390/v15020370}
}
EUVIMED